Amicus Therapeutics, Inc.FOLDNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+21.6%
5Y CAGR+19.6%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+21.6%/yr
vs +13.8%/yr prior
5Y CAGR
+19.6%/yr
Consistent
Acceleration
+7.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $383.49M | +18.6% |
| 2024 | $323.38M | +17.5% |
| 2023 | $275.27M | +29.2% |
| 2022 | $213.04M | +10.6% |
| 2021 | $192.71M | +23.2% |
| 2020 | $156.41M | -7.9% |
| 2019 | $169.86M | +33.5% |
| 2018 | $127.20M | +43.5% |
| 2017 | $88.67M | +24.6% |
| 2016 | $71.15M | - |